Planta Med 2008; 74(3): 252-257
DOI: 10.1055/s-2008-1034317
Pharmacology
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Ampelopsin Prevents Apoptosis Induced by H2O2 in MT-4 Lymphocytes

Jiantao Ye1 [*] , Yongyuan Guan2 [*] , Sa Zeng1 , Deyu Liu1
  • 1School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, People’s Republic of China
  • 2Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of China
Further Information

Publication History

Received: August 23, 2007 Revised: January 13, 2008

Accepted: January 15, 2008

Publication Date:
26 February 2008 (online)

Abstract

Human immunodeficiency virus (HIV) infection can result in oxidative stress through production of reactive oxygen species (ROS). Simultaneously, oxidative stress is able to activate the replication of virus and lead to the apoptosis of T lymphocytes which is the defense of the immune function. Ampelopsin, belonging to the flavonoids, is a purified component from the root of a Chinese medicinal herb. Our previous studies revealed that ampelopsin could protect sensitive cells against HIV-1 infection and reduce HIV-1 antigen P24 expression. In this study, we determined whether ampelopsin, as an antioxidant, has protective effects on oxidant stress-induced apoptosis in MT-4 cells, a CD4 T lymphocyte cell line. The results indicate that ampelopsin scavenged hydroxyl radicals (·OH) and superoxide radicals (O2 .-) in a concentration-dependent manner. It significantly increased MT-4 cells viability after treatment with H2O2 and inhibited H2O2-induced DNA laddering. The data from flow cytometry analysis showed that ampelopsin remarkably decreased the percentage of apoptotic cells induced by H2O2. In addition, activation of caspase-3 was detected during the course of apoptosis induction. Western blot analysis showed that ampelopsin inhibited the cleavage of caspase-3 induced by H2O2. All these findings might shed new light on the understanding of the anti-AIDS functions of ampelopsin by protecting T cells of persons infected with HIV.

References

  • 1 Appay V, Papagno L, Spina C A, Hansasuta P, King A, Jones L. et al . Dynamics of T cell responses in HIV infection.  J Immunol. 2002;  168 3660-6
  • 2 Varbanov M, Espert L, Biard-Piechaczyk M. Mechanisms of CD4 T-cell depletion triggered by HIV-1 viral proteins.  AIDS Rev. 2006;  8 221-36
  • 3 Holm G H, Gabuzda D. Distinct mechanisms of CD4 and CD8 T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions.  J Virol. 2005;  79 6299-311
  • 4 Elbim C, Pillet S, Prevost M H, Preira A, Girard P M, Rogine N. et al . Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load.  J Virol. 1999;  73 4561-6.
  • 5 Stephensen C B, Marquis G S, Douglas S D, Kruzich L A, Wilson C M. Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults.  Am J Clin Nutr. 2007;  85 173-81
  • 6 Williams S A, Kwon H, Chen L F, Greene W C. Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1.  J Virol. 2007;  81 6043-56
  • 7 Oiry J, Mialocq P, Puy J Y, Fretier P, Dereuddre-Bosquet N, Dormont D. et al . Synthesis and biological evaluation in human monocyte-derived macrophages of N-(N-acetyl-L-cysteinyl)-S-acetylcysteamine analogues with potent antioxidant and anti-HIV activities.  J Med Chem. 2004;  47 1789-95
  • 8 Fawzi W W, Msamanga G I, Spiegelman D, Wei R, Kapiga S, Villamor E. et al . A randomized trial of multivitamin supplements and HIV disease progression and mortality.  N Engl J Med. 2004;  351 23-32.
  • 9 Gil L, Perez D, Tapanes R, Perez J, Grune T. Does mitochondrial dysfunction during antiretroviral therapy in human immunodeficiency virus infection suggest antioxidant supplementation as a beneficial option?.  Redox Rep. 2005;  10 113-9
  • 10 Liu D Y, Ye J T, Yang W H, Yan J, Zeng C H, Zeng S. Ampelopsin, a small molecule inhibitor of HIV-1 infection targeting HIV entry.  Biomed Environ Sci. 2004;  17 153-64
  • 11 Noroozi M, Angerson W J, Lean M E. Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes.  Am J Clin Nutr. 1998;  67 1210-8
  • 12 Rusak G, Gutzeit H O, Muller J L. Structurally related flavonoids with antioxidative properties differentially affect cell cycle progression and apoptosis of human acute leukemia cells.  Nutr Res. 2005;  25 141-52
  • 13 Mallery S R, Pei P, Landwehr D J, Clark C M, Bradburn J E, Ness G M. et al . Implications for oxidative and nitrative stress in the pathogenesis of AIDS-related Kaposi′s sarcoma.  Carcinogenesis. 2004;  25 597-603
  • 14 Aukrust P, Muller F, Svardal A M, Ueland T, Berge R K, Froland S S. Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy - potential immunomodulatory effects of antioxidants.  J Infect Dis. 2003;  188 232-8
  • 15 Carlisle M L, King M R, Karp D R. Gamma-glutamyl transpeptidase activity alters the T cell response to oxidative stress and Fas-induced apoptosis.  Int Immunol. 2003;  15 17-27
  • 16 Dandekar D H, Ganesh K N, Mitra D. HIV-1 Tat directly binds to NFkappaB enhancer sequence: role in viral and cellular gene expression.  Nucleic Acids Res. 2004;  32 1270-8
  • 17 Tan P H, Sagoo P, Chan C, Yates J B, Campbell J, Beutelspacher S C. et al . Inhibition of NF-kappaB and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells.  J Immunol. 2005;  174 7633-44
  • 18 Muller F, Svardal A M, Nordoy I, Berge R K, Aukrust P, Froland S S. Virological and immunological effects of antioxidant treatment in patients with HIV infection.  Eur J Clin Invest. 2000;  30 905-14
  • 19 McDermid J M, Lalonde R G, Gray-Donald K, Baruchel S, Kubow S. Associations between dietary antioxidant intake and oxidative stress in HIV-seropositive and HIV-seronegative men and women.  J Acquir Immune Defic Syndr. 2002;  29 158-64
  • 20 Yano S, Yano N. Regulation of catalase enzyme activity by cell signaling molecules.  Mol Cell Biochem. 2002;  240 119-30
  • 21 Gulow K, Kaminski M, Darvas K, Suss D, Li-Weber M, Krammer P H. HIV-1 trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death.  J Immunol. 2005;  174 5249-60
  • 22 Shen H M, Liu Z G. JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species.  Free Radic Biol Med. 2006;  40 928-39
  • 23 Holm G H, Zhang C, Gorry P R, Peden K, Schols D, de Clercq E. et al . Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure.  J Virol. 2004;  78 4541-51
  • 24 Gloire G, Legrand-Poels S, Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later.  Biochem Pharmacol. 2006;  72 1493-505
  • 25 Chiaramonte R, Bartolini E, Riso P, Calzavara E, Erba D, Testolin G. et al . Oxidative stress signalling in the apoptosis of Jurkat T-lymphocytes.  J Cell Biochem. 2001;  82 437-44
  • 26 Yakes F M, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress.  Proc Natl Acad Sci USA. 1997;  94 514-9
  • 27 Jaruga P, Jaruga B, Gackowski D, Olczak A, Halota W, Pawlowska M. et al . Supplementation with antioxidant vitamins prevents oxidative modification of DNA in lymphocytes of HIV-infected patients.  Free Radic Biol Med. 2002;  32 414-20

1 These authors contributed equally to this work.

Prof. Deyu Liu

School of Pharmaceutical Sciences

Sun Yat-sen University

74 Zhongshan 2 Road

Guangzhou 510089

People’s Republic of China

Phone: +86-20-8733-1476

Fax: +86-20-8733-1476

Email: liudeyu@mail.sysu.edu.cn